Clinical Trials Browser

Phase 1 × fosbretabulin × Tumor-Agnostic × Clear all

NCT00395434 2011-10-31

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasm Metastasis, Neoplasms